Theravance Inc (NASDAQ:THRX)

16.62
Delayed Data
As of May 26
 -0.03 / -0.18%
Today’s Change
10.58
Today|||52-Week Range
31.80
+17.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues934.0K4.2M10.7M10.4M
 
 
 
 
 
Depreciation And Amortization2.0M6.9M3.5M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.8M6.9M7.2M6.1M
 
 
 
 
 
Research And Development2.1M1.9M777.0K712.0K
 
 
 
 
 
Total Operating Expenses10.7M13.8M10.6M9.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.8M-9.5M130.0K745.0K
 
 
 
 
 
Interest Expense On Debt10.3M12.4M12.6M12.7M
 
 
 
 
 
Other Expenses83.0K255.0K-3.6M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.9M-21.5M-15.9M-10.7M
 
 
 
 
 
Income Taxes-278.0K-278.0K0.000.00
 
 
 
Discontinued Operations-43.4M0.000.000.00
 
 
Net Income-63.6M-21.3M-15.9M-10.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS111.0M113.1M114.3M114.7M
 
 
 
 
 
Shares To Calculate EPS Diluted111.0M113.1M114.3M114.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.57-$0.19-$0.14-$0.09
 
 
 
 
 
EPS Diluted-$0.57-$0.19-$0.14-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account